Related Experiment Video

Updated: Feb 16, 2026

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
12:24

PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins

Published on: July 2, 2010

54.2K

RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment

Suntaek Hong1

  • 1Department of Biochemistry, College of Medicine, Gachon University, Incheon, Korea.

Journal of Cancer Prevention
|January 6, 2018
PubMed

Insights

RNA binding proteins (RBPs) are crucial for RNA function but are often dysregulated in cancer. Understanding RBP-RNA interactions is key to developing new cancer therapies and biomarkers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • RNA binding proteins (RBPs) are essential for RNA biological functions.
  • RBPs interact with RNA through specific domains, influenced by sequence and structure.
  • Dysregulation of RBPs, via genetic or epigenetic changes, is common in human cancers.

Purpose of the Study:

  • To explore the role of dysregulated RNA binding proteins (RBPs) in cancer development and progression.
  • To highlight therapeutic strategies targeting RBP-RNA interactions for cancer treatment.
  • To emphasize the importance of identifying RBP targets for novel cancer biomarkers.

Main Methods:

  • Review of mechanisms of RBP dysregulation in cancer (genetic, epigenetic, etc.).
  • Analysis of RBP influence on cancer hallmarks (proliferation, apoptosis, metastasis).
  • Discussion of therapeutic approaches targeting RBP-RNA interactions, including RNA interference and small molecules.

Main Results:

  • Aberrant RBP regulation contributes to cancer initiation and progression.
  • RBPs impact key cancer processes such as cell proliferation, apoptosis evasion, immune surveillance, angiogenesis, and metastasis.
  • High-throughput identification of RBP-binding RNAs and integrated data analysis are crucial.

Conclusions:

  • Targeting dysregulated RBPs offers promising therapeutic avenues for cancer.
  • Identifying specific RBP-RNA interactions can lead to the development of novel prognostic biomarkers.
  • Further research into RBP functions in cancer is essential for advancing treatment strategies.
Keywords:
CancerChemopreventionRNA-binding proteinsTherapeutics

More Related Videos

An Assay for Quantifying Protein-RNA Binding in Bacteria07:02

An Assay for Quantifying Protein-RNA Binding in Bacteria

Published on: June 12, 2019

7.0K
An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA07:55

An Optimized Quantitative Pull-Down Analysis of RNA-Binding Proteins Using Short Biotinylated RNA

Published on: February 17, 2023

5.4K

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.1K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K